NASDAQ
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) has a price/sales ratio of 5.31x as of Friday, May 22, 2026. This represents a 23.61% increase compared to its 12-month average of 4.29x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.